Cryoablation offers a minimally invasive treatment option for patients as an alternative to surgery.
Pleasanton CA (PRWEB)
June 28, 2017
Sanarus Technologies, an advanced cryoablation company and developer of the Visica® 2 Treatment System, today announced the addition of Govindarajan “Raj” Narayanan, MD to its board of directors. A professor of interventional radiology and chairman of the Department of Interventional Radiology at the University of Miami Miller School of Medicine, Dr. Narayanan brings a wealth of academic and clinical expertise to the appointment, including his unique experience in clinical research trials. In addition, Dr. Narayanan is board-certified in diagnostic radiology and holds a Certificate of Added Qualification (CAQ) in Interventional Radiology.
“We are proud to have the opportunity to work with Dr. Narayanan as we continue to leverage technology to scale our expert clinicians to improve the health of people with certain cancers,” said BJ Hardman, Chairman and CEO of Sanarus Technologies. “Dr. Narayanan has extraordinary clinical and academic expertise, and we are delighted that he is joining our board.”
Sanarus Technologies’ mission is to advance minimally invasive cryoablation treatment for patients with certain cancers through the development, manufacturing and marketing of innovative technology used by radiologists and surgeons. With Dr. Narayanan’s appointment to the board of directors, Sanarus demonstrates its commitment to partner with key opinion leaders to further accelerate growth.
“Interventional radiologists are diagnosing cancer in the earliest stages and managing it with more precise, less invasive treatment,” said Dr. Narayanan. “Cryoablation offers a minimally…